Close Menu

Within every industry, there's an Apple or a GE, says Luke Timmerman at Xconomy"anchors" or "models of success" that other companies in that industry look up to. In biotech, that role has been filled by companies like Genentech and Genzyme, Timmerman adds, but because of buyouts and mergers in almost every regional cluster, the industry is losing its anchors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.